Magnesium Supplementation Lowers Blood Pressure in Hypertension, reveals research

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-10-07 02:30 GMT   |   Update On 2025-10-07 07:26 GMT
Advertisement

Researchers have established in a new study that supplementation with magnesium lowers blood pressure (BP) among hypertensive and hypomagnesemic patients substantially but to a lesser extent in normotensive subjects. The research was published in the journal of Hypertension by Zoe A. and colleagues.

Investigators conducted a meta-analysis and dose-response analysis of randomized controlled trials lasting at least 4 weeks. A total of 38 trials, including 2,709 participants, were analyzed. The elemental magnesium dose in the studies ranged from 82.3 mg to 637 mg, with a median daily dose of 365 mg, and the median intervention period was 12 weeks. Statistical analysis with cubic spline regression was conducted and outcomes were combined using random-effects meta-analysis.

Advertisement

Results

• As a whole, magnesium supplementation was linked to a -2.81 mm Hg (95% CI, -4.32 to -1.29) systolic BP decrease and a -2.05 mm Hg (95% CI, -3.23 to -0.88) diastolic BP decrease compared with placebo.

• Hypertensive patients on BP-lowering medication: systolic BP fell by -7.68 mm Hg, diastolic BP by -2.96 mm Hg (P<0.05).

• Patients with hypomagnesemia: systolic BP fell by -5.97 mm Hg, diastolic BP by -4.75 mm Hg (P<0.05).

• Conversely, in normotensive groups, decreases did not achieve statistical significance. Notably, no dose-response was found between magnesium supplementation and BP change (all P ≥ 0.20), and high heterogeneity was detected between trials.

But since no dose-response pattern is evident and high variability exists across trials, intake of magnesium cannot be viewed as a standardized therapy yet. Based on the conclusion of the study, magnesium supplementation is associated with a decrease in blood pressure in hypertensive and hypomagnesemia populations but not in normotensive individuals. Due to high heterogeneity between studies, larger well-conducted clinical trials are required to clarify the dose-response association and establish the best supplementation regimens for different subgroups.

Reference:

Argeros, Z., Xu, X., Bhandari, B., Harris, K., Touyz, R. M., & Schutte, A. E. (2025). Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension (Dallas, Tex. : 1979), 10.1161/HYPERTENSIONAHA.125.25129. Advance online publication. https://doi.org/10.1161/HYPERTENSIONAHA.125.25129
Tags:    
Article Source : Hypertension

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News